203-815-1

应用筛选条件

关键词:'203-815-1'

显示 1-16 共 16 条结果关于 "203-815-1" 范围技术文档

Anti-HA Affinity Matrix Anti-HA Affinity Matrix 1 ml 1 ml 11 815 016 001 11 815 016 001 HA Peptide HA Peptide

New Zealand +64 06 356 7328 Mexico +52 81 8158 0600 Pakistan +92 21 455 9210 Peru +51 1 6187 500 Phillipines +63 2 815 4067 Singapore +65 6890 6638 Taiwan +886 2 2742 2788 Thailand +66 2 667 8333 Venezuela

In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation

Turner, C. H., Qiu, J., Tu, Y., Onyia, J. E. & Duncan, R. L. (1997) Am. J. Physiol. C 273, 810–815. 21. Tanaka, S. M., Sun, H. B., Roeder, R. K., Burr, D. B., Turner, C. H. & Yokota,

XP725 Antibody List Lot 129K4831

y n/d n/d 386 Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin

XP725 Antibody List Lot 129K4830

y n/d n/d 386 Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin

XP725 Antibody List Lot 089K4791

y n/d n/d 386 Importin-a3 I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin

XP725 Antibody List

n/d 201 Cystatin A C3095 1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin

XP725 Antibody List 013M4793

n/d 201 Cystatin A C3095 1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin

Calbiochem Biologics 32.4

Pan, G ., et al . 1997 . Science 277, 815; Sheridan, J .P ., et al . 1997 . Science 277, 818; Pitti, R .M ., et al . 1996 . J. Biol. Chem. 271, 12687; cIAP-1

Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns

5.0 with acetic acid; (B) water; (C) acetonitrile; (9:1:90, A:B:C) mixing proportions: A:B:C = 9:1:90 Flow Rate: 0.6 mL/min Pressure: 815 psi Temp.: 35 °C Det.: UV at 254 nm; ELSD, 55 °C

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

Anti-phospho-Raf-1 (Ser621) H WB APur Rb IgG 100 µL 07-813 Anti-phospho-Raf-1 (Ser338/Tyr340) H WB APur Rb IgG 100 µL 07-814 Anti-phospho-Raf-1 (Tyr340/Tyr341) H WB APur Rb IgG 100 µL 07-815 Assay

Cytoskeletal Signaling Antibodies, Reagents and Kits

anti-phospho-Raf-1 (Ser621) H WB APur Rb IgG 100 µL 07-813 anti-phospho-c-Raf (Ser338/Tyr340) H WB APur Rb IgG 100 µL 07-814 anti-phospho-Raf-1 (Tyr340/Tyr341) H WB APur Rb IgG 100 µL 07-815 Assay

Halal Certificate

ORGANIC (NOP) W262440 B44426 HC-23SIB552 814. LEVULINIC ACID 97%, FG W262706 B80363 HC-23SI4L04 815. LEVULINIC ACID, NATURAL W262701 C37182 HC-23SI3D26 816. L-FENCHONE 98% W507709 A48344 HC-23SIIN68

Halal Certificate

ORGANIC (NOP) W262440 B44426 HC-22SI9A73 814. LEVULINIC ACID 97%, FG W262706 B80363 HC-22SI7X25 815. LEVULINIC ACID, NATURAL W262701 C37182 HC-22SI8U47 816. L-FENCHONE 98% W507709 A48344 HC-22SIFC89

XP725 Worksheet for Lot Number 071M4826

L3414 812 5 1 6 4 LAP2 TMPO L3414 813 5 1 6 5 Leptin L3410 814 5 1 6 6 Leptin L3410 815 5 1 6 7 Anti CY3/5 C0992 816 5 1 6 8 Anti CY3/5 C0992 817 5 2 1 1 LIM Kinase1

Chrombook (WEB-Version)

Sample 1. Nadolol 100 mg/mL 2. Metoprolol 100 mg/mL 3. Propranolol 50 mg/mL www.merck-chemicals.com/analytical-hplc Analytical HPLC 203 Chromolith® SemiPrep 0 mAU 0 1 2 3